Esser MB, Leung G, Sherk A, Bohm MK, Liu Y, Lu H, Naimi TS. Estimated deaths attributable to excessive alcohol use among us adults aged 20 to 64 years, 2015 to 2019. JAMA Netw Open. 2022;5:e2239485.

Article  PubMed  PubMed Central  Google Scholar 

2021 NSDUH Detailed Tables. https://www.samhsa.gov/data/report/2021-nsduh-detailed-tables. Accessed 3 Sep 2023.

Spillane S, Shiels MS, Best AF, Haozous EA, Withrow DR, Chen Y, de Gonzalez AB, Freedman ND. Trends in alcohol-induced deaths in the United States, 2000–2016. JAMA Netw Open. 2020;3:e1921451.

Article  PubMed  PubMed Central  Google Scholar 

Collaborators GBDA. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2016. https://doi.org/10.1016/S0140-6736(18)31310-2.

Article  Google Scholar 

Englander H, King C, Nicolaidis C, Collins D, Patten A, Gregg J, Korthuis PT. Predictors of opioid and alcohol pharmacotherapy initiation at hospital discharge among patients seen by an inpatient addiction consult service. J Addict Med. 2020;14:415–22.

Article  PubMed  PubMed Central  Google Scholar 

Singh JA, Cleveland JD. Trends in hospitalizations for alcohol use disorder in the US from 1998 to 2016. JAMA Netw Open. 2020;3:e2016580.

Article  PubMed  Google Scholar 

Pollard MS, Tucker JS, Green HD Jr. Changes in adult alcohol use and consequences during the COVID-19 pandemic in the US. JAMA Netw Open. 2020;3:e2022942.

Article  PubMed  PubMed Central  Google Scholar 

Velez CM, Nicolaidis C, Korthuis PT, Englander H. “It’s been an experience, a life learning experience”: a qualitative study of hospitalized patients with substance use disorders. J Gen Intern Med. 2017;32:296–303.

Article  PubMed  Google Scholar 

Makdissi R, Stewart SH. Care for hospitalized patients with unhealthy alcohol use: a narrative review. Addict Sci Clin Pract. 2013;8:11.

Article  PubMed  PubMed Central  Google Scholar 

Sacco P, Unick GJ, Kuerbis A, Koru AG, Moore AA. Alcohol-related diagnoses in hospital admissions for all causes among middle-aged and older adults: trends and cohort differences from 1993 to 2010. J Aging Health. 2015;27:1358–74.

Article  PubMed  PubMed Central  Google Scholar 

Zemore SE, Karriker-Jaffe KJ, Mulia N, Kerr WC, Ehlers CL, Cook WK, Martinez P, Lui C, Greenfield TK. The future of research on alcohol-related disparities across U.S. racial/ethnic groups: a plan of attack. J Stud Alcohol Drugs. 2018;79:7–21.

Article  PubMed  PubMed Central  Google Scholar 

Kiluk BD, Ray LA, Walthers J, Bernstein M, Tonigan JS, Magill M. Technology-delivered cognitive-behavioral interventions for alcohol use: a meta-analysis. Alcohol Clin Exp Res. 2019;43:2285–95.

Article  PubMed  PubMed Central  Google Scholar 

Englander H, Dobbertin K, Lind BK, Nicolaidis C, Graven P, Dorfman C, Korthuis PT. Inpatient addiction medicine consultation and post-hospital substance use disorder treatment engagement: a propensity-matched analysis. J Gen Intern Med. 2019;34:2796–803.

Article  PubMed  PubMed Central  Google Scholar 

NIH research Portfoli Online Reporting Tools (RePORT). Oral V Injection naltrexone in hospital: comparative effectiveness for alcoholism. https://projectreporter.nih.gov/project_info_description.cfm? aid=9539171&icde=53768896&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC&pball=. Accessed 3 Sep 2023.

Busch AC, Denduluri M, Glass J, Hetzel S, Gugnani SP, Gassman M, Krahn D, Deyo B, Brown R. Predischarge injectable versus oral naltrexone to improve postdischarge treatment engagement among hospitalized veterans with alcohol use disorder: a randomized pilot proof-of-concept study. Alcohol Clin Exp Res. 2017;41:1352–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kirchoff RW, Mohammed NM, McHugh J, Markota M, Kingsley T, Leung J, Burton MC, Chaudhary R. Naltrexone initiation in the inpatient setting for alcohol use disorder: a systematic review of clinical outcomes. Mayo Clin Proc Innov Qual Outcomes. 2021;5:495–501.

Article  PubMed  PubMed Central  Google Scholar 

Terasaki D, Loh R, Cornell A, Taub J, Thurstone C. Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates. Addict Sci Clin Pract. 2022;17:64.

Article  PubMed  PubMed Central  Google Scholar 

Leung JG, Narayanan PP, Markota M, Miller NE, Philbrick KL, Burton MC, Kirchoff RW. Assessing naltrexone prescribing and barriers to initiation for alcohol use disorder: a multidisciplinary. Multisite Surv Front Psychiatry. 2022;13:856938.

Article  Google Scholar 

Tigh J, Daniel K, Balasanova AA. Impact of hospital-administered extended-release naltrexone on readmission rates in patients with alcohol use disorder: a pilot study. Prim Care Companion CNS Disord. 2022;24:43569.

Article  Google Scholar 

Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50:217–26.

Article  PubMed  PubMed Central  Google Scholar 

Hagedorn HJ, Stetler CB, Bangerter A, Noorbaloochi S, Stitzer ML, Kivlahan D. An implementation-focused process evaluation of an incentive intervention effectiveness trial in substance use disorders clinics at two Veterans Health Administration medical centers. Addict Sci Clin Pract. 2014;9:12.

Article  PubMed  PubMed Central  Google Scholar 

Zemore SE, Ye Y, Mulia N, Martinez P, Jones-Webb R, Karriker-Jaffe K. Poor, persecuted, young, and alone: toward explaining the elevated risk of alcohol problems among Black and Latino men who drink. Drug Alcohol Depend. 2016;163:31–9.

Article  PubMed  PubMed Central  Google Scholar 

Ransome Y, Carty DC, Cogburn CD, Williams DR. Racial disparities in the association between alcohol use disorders and health in black and white women. Biodemography Soc Biol. 2017;63:236–52.

Article  PubMed  PubMed Central  Google Scholar 

Inpatient stays involving mental and substance use disorders. 2016. https://www.hcup-us.ahrq.gov/reports/statbriefs/sb249-Mental-Substance-Use-Disorder-Hospital-Stays-2016.pdf. Accessed 3 Sep 2023.

U.S. Department of Health and Human Services. Facing addiction in America: the surgeon general’s report on alcohol, drugs, and health. Washington: HHS; 2016.

Google Scholar 

Ray LA, Meredith LR, Kiluk BD, Walthers J, Carroll KM, Magill M. Combined pharmacotherapy and cognitive behavioral therapy for adults with alcohol or substance use disorders: a systematic review and meta-analysis. JAMA Netw Open. 2020;3:e208279.

Article  PubMed  PubMed Central  Google Scholar 

Sholomskas DE, Syracuse-Siewert G, Rounsaville BJ, Ball SA, Nuro KF, Carroll KM. We don’t train in vain: a dissemination trial of three strategies of training clinicians in cognitive-behavioral therapy. J Consult Clin Psychol. 2005;73:106–15.

Article  PubMed  PubMed Central  Google Scholar 

Greist JH. A promising debut for computerized therapies. Am J Psychiatry. 2008;165:793–5.

Article  PubMed  Google Scholar 

Carroll KM, Rounsaville BJ. Computer-assisted therapy in psychiatry: be brave—it’s a new world. Curr Psychiatry Rep. 2010;12:426–32.

Article  PubMed  PubMed Central  Google Scholar 

Postel MG, de Jong CA, de Haan HA. Does e-therapy for problem drinking reach hidden populations? Am J Psychiatry. 2005;162:2393.

Article  PubMed  Google Scholar 

Marks IM, Cavanagh K. Computer-aided psychological treatments: evolving issues. Annu Rev Clin Psychol. 2009;5:121.

Article  PubMed  Google Scholar 

McCaul ME, Svikis DS, Moore RD. Predictors of outpatient treatment retention: patient versus substance use characteristics. Drug Alcohol Depend. 2001;62:9–17.

Article  CAS  PubMed  Google Scholar 

Matsuzaka S, Knapp M. Anti-racism and substance use treatment: addiction does not discriminate, but do we? J Ethn Subst Abuse. 2020;19:567–93.

Article  PubMed  Google Scholar 

Kiluk BD, Devore KA, Buck MB, Nich C, Frankforter TL, LaPaglia DM, Yates BT, Gordon MA, Carroll KM. Randomized trial of computerized cognitive behavioral therapy for alcohol use disorders: efficacy as a virtual stand-alone and treatment add-on compared with standard outpatient treatment. Alcohol Clin Exp Res. 2016;40:1991–2000.

Article  PubMed  PubMed Central  Google Scholar 

Paris M, Silva M, Anez-Nava L, Jaramillo Y, Kiluk BD, Gordon MA, Nich C, Frankforter T, Devore K, Ball SA, Carroll KM. Culturally adapted, web-based cognitive behavioral therapy for Spanish-speaking individuals with substance use disorders: a randomized clinical trial. Am J Public Health. 2018;108:1535–42.

Article  PubMed  PubMed Central  Google Scholar 

King C, Nicolaidis C, Korthuis PT, Priest KC, Englander H. Patterns of substance use before and after hospitalization among patients seen by an inpatient addiction consult service: a latent transition analysis. J Subst Abuse Treat. 2020;118:108121.

Article  PubMed  PubMed Central  Google Scholar 

Jordan A, Quainoo S, Nich C, Babuscio TA, Funaro M, Carroll KM: An evaluation of racial/ethnic disparities in alcohol, cannabis, and illicit substance use treatment initiation, engagement, and treatment outcome: a systematic review of randomized clinical trials.

Hahn JA, Murnane PM, Vittinghoff E, Muyindike WR, Emenyonu NI, Fatch R, Chamie G, Haberer JE, Francis JM, Kapiga S, et al. Factors associated with phosphatidylethanol (PEth) sensitivity for detecting unhealthy alcohol use: an individual patient data meta-analysis. Alcohol Clin Exp Res. 2021;45:1166–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Johansson K, Johansson L, Pennlert J, Soderberg S, Jansson JH, Lind MM. Phosphatidylethanol levels, as a marker of alcohol consumption, are associated with risk of intracerebral hemorrhage. Stroke. 2020;51:2148–52.

Article  CAS  PubMed